These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21999410)

  • 21. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.
    Delacourte A; Sergeant N; Champain D; Wattez A; Maurage CA; Lebert F; Pasquier F; David JP
    Neurology; 2002 Aug; 59(3):398-407. PubMed ID: 12177374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    Näslund J; Haroutunian V; Mohs R; Davis KL; Davies P; Greengard P; Buxbaum JD
    JAMA; 2000 Mar 22-29; 283(12):1571-7. PubMed ID: 10735393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
    Tran HT; LaFerla FM; Holtzman DM; Brody DL
    J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau, beta-amyloid and beta-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain.
    Shukla C; Bridges LR
    Neurosci Lett; 2001 May; 303(3):193-7. PubMed ID: 11323118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
    Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
    J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
    Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
    J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.
    Kristofikova Z; Ricny J; Kolarova M; Vyhnalek M; Hort J; Laczo J; Sirova J; Ripova D
    J Alzheimers Dis; 2014; 42 Suppl 3():S91-8. PubMed ID: 24670397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.
    Fagan AM; Shaw LM; Xiong C; Vanderstichele H; Mintun MA; Trojanowski JQ; Coart E; Morris JC; Holtzman DM
    Arch Neurol; 2011 Sep; 68(9):1137-44. PubMed ID: 21555603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
    Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
    Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of deposition of tau and amyloid-β proteins with structural connectivity changes in cognitively normal older adults and Alzheimer's disease spectrum patients.
    Shigemoto Y; Sone D; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
    Brain Behav; 2018 Dec; 8(12):e01145. PubMed ID: 30358161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging.
    Cummings BJ; Mason AJ; Kim RC; Sheu PC; Anderson AJ
    Neurobiol Aging; 2002; 23(2):161-70. PubMed ID: 11804699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.